These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16359844)

  • 1. A neural network model of Parkinson's disease bradykinesia.
    Cutsuridis V; Perantonis S
    Neural Netw; 2006 May; 19(4):354-74. PubMed ID: 16359844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origins of a repetitive and co-contractive biphasic pattern of muscle activation in Parkinson's disease.
    Cutsuridis V
    Neural Netw; 2011 Aug; 24(6):592-601. PubMed ID: 21447437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
    Liang CL; Wang TT; Luby-Phelps K; German DC
    Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for altered neural network dynamics related to prehension movements in Parkinson disease.
    Molina-Vilaplana J; Contreras-Vidal JL; Herrero-Ezquerro MT; Lopez-Coronado J
    Biol Cybern; 2009 Apr; 100(4):271-87. PubMed ID: 19229555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology.
    Bartels AL; Leenders KL
    Cortex; 2009 Sep; 45(8):915-21. PubMed ID: 19095226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.
    Vernier P; Moret F; Callier S; Snapyan M; Wersinger C; Sidhu A
    Ann N Y Acad Sci; 2004 Dec; 1035():231-49. PubMed ID: 15681811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bradykinesia in Parkinson's disease with increased movement complexity: elbow flexion-extension movements.
    Moroney R; Heida C; Geelen J
    J Comput Neurosci; 2008 Dec; 25(3):501-19. PubMed ID: 18618234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling basal ganglia for understanding Parkinsonian reaching movements.
    Magdoom KN; Subramanian D; Chakravarthy VS; Ravindran B; Amari S; Meenakshisundaram N
    Neural Comput; 2011 Feb; 23(2):477-516. PubMed ID: 21105828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
    Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
    Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in neuronal firing rates in pallidal and cerebellar receiving areas of thalamus in patients with Parkinson's disease, essential tremor, and pain.
    Molnar GF; Pilliar A; Lozano AM; Dostrovsky JO
    J Neurophysiol; 2005 Jun; 93(6):3094-101. PubMed ID: 15703231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of functional imaging to understanding parkinsonian symptoms.
    Grafton ST
    Curr Opin Neurobiol; 2004 Dec; 14(6):715-9. PubMed ID: 15582373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.